United States precision medicine market is expected to grow at a significant rate during the forecast period. The growing need for customized personal healthcare treatment as each person reacts in a different way to medicines which enhances the effectiveness of treatment is driving the market for precision medicine. Precision medicines are person specific and are more precise, personalized, and powerful way of treating patients. Strong economic position and rising GDP is enabling to allocate huge funds for development of healthcare sector in United States.
Presence of disposable income among the residents of United States is aiding to increase the expenditure capacity of consumers. Market players are engaging in research and development activities for producing advanced medicines which are more effective, have longer shelf life and can be made according to the patient’s needs. Supportive government policies to support healthcare infrastructure and increase the access of healthcare services to every sector of society in form of reimbursement policies is contributing to increase the precision market growth. Accessibility to large scale human genome databases including whole genome sequencing and next generation sequencing is fueling the demand for precision medicines in United States for the next five years.
United States precision medicine market is segmented into
The major players operating in the United States precision medicine market are Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN Inc., Quest Diagnostics, Inc., Pfizer Inc., Agilent Technologies, Inc., Medtronic USA, Inc., Orion Health Inc., Celcuity Inc., InsightRX Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.
Objective of the Study
- To analyze the historical growth of the market size of United States precision medicine market from 2017 to 2020.
- To estimate and forecast the market size of United States precision medicine market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States precision medicine market based on products and services, technology, application, end-user, regional distribution, and company.
- To identify dominant region or segment in the United States precision medicine.
- To identify drivers and challenges for United States precision medicine market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States precision medicine market.
- To identify and analyze the profile of leading players operating in United States precision medicine market.
- To identify key sustainable strategies adopted by market players in United States precision medicine market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of manufacturers across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
Market insights research calculated the market size of
Key Target Audience
- Precision medicine manufacturing companies
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to precision medicine market.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Attribute | Details |
Base Year | 2021 |
Historical Years | 2017 – 2020 |
Estimated Year | 2022E |
Forecast Period | 2023F – 2027F |
Quantitative Units | Revenue in USD Million and CAGR for 2017-2021 and 2022E-2027F |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | - Products and Services
- Technology
- Application
- End User
|
Region Scope | South-Region, West-Region, Mid-West Region & Northeast-Region |
Key Companies Profiled | Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN Inc., Quest Diagnostics, Inc., Pfizer Inc., Agilent Technologies, Inc., Medtronic USA, Inc., Orion Health Inc., Celcuity Inc., InsightRX Inc. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |